Clinical Use of Cystatin C in 2026
About This Webcast
Presented by: Michael G. Shlipak, MD, MPH Scientific Director Kidney Health Research Collaborative Professor of Medicine Epidemiology & Biostatistics UCSF As healthcare systems advance precision diagnostics and risk stratification, integrating Cystatin C into routine practice is increasingly important. An inexpensive measure of kidney function, Cystatin C offers advantages over serum creatinine, including fewer non-GFR determinants and improved CKD diagnosis, staging, and prognosis. For most ambulatory patients, the combined creatinine and Cystatin C equation provides the most accurate estimate of GFR. In this webinar, Dr. Michael G. Shlipak will deliver practical, evidence-based guidance for incorporating Cystatin C testing into clinical care. Continuing education credit will be offered for this session.